Grants for Public and State controlled institutions of higher education - Federal

This funding opportunity supports U.S. institutions and organizations in developing animal models and biological resources to advance research on Down syndrome and its related health conditions.

This funding opportunity supports U.S.-based institutions in enhancing the accessibility and usability of planetary science data through archiving, restoration, and tool development, with provisions for international participation.

This program provides funding to researchers and organizations to develop innovative technologies that improve teamwork between humans and intelligent agents in military operations.

This funding opportunity provides support for the ongoing development and maintenance of valuable informatics tools and resources that enhance cancer research and management, benefiting researchers and the broader cancer community.

The purpose of the NIH Midcareer Investigator Award in Patient-Oriented Research (K24) is to provide support to mid-career health-professional doctorates for protected time to devote to patient-oriented research (POR) and to act as research mentors primarily for clinical residents, clinical fellows and/or junior clinical faculty. Section I. Funding Opportunity Description The overall goal of the NIH Research Career Development program is to help ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address the Nation's biomedical, behavioral, and clinical research needs. NIH Institutes and Centers (ICs) support a variety of mentored and non-mentored career development award programs designed to foster the transition of new investigators to research independence and to support established investigators in achieving specific objectives. Candidates should review the different career development (K) award programs to determine the best program to support their goals. More information about Career programs may be found at the NIH Extramural Training Mechanisms website. The NIH Midcareer Investigator Award in Patient-Oriented Research (K24) is designed to enable mid-career clinician-scientists to: Devote more time to augment their capabilities in Patient-Oriented Research (POR); and Provide mentoring to junior clinical investigators in the conduct of POR (see below for definition). The K24 award is intended to provide protected time to mid-career clinical investigators to provide mentoring to junior clinical investigators, particularly K23 grantees, in POR and to stabilize the careers of these investigators. The intent is to allow these investigators to continue to conduct POR and be available as mentors in POR. It is expected that K24 recipients will obtain new or additional independent, peer-reviewed funding for POR as PD/PI and establish and assume leadership roles in collaborative POR programs. In addition, it is expected that there will be an increased effort and commitment to act as a mentor to beginning clinician investigators in POR to enhance the research productivity of both the K24 investigator and increase the pool of well-trained clinical researchers of the future. For the purposes of the K24 award, Patient-Oriented Research is defined as research conducted with human subjects (or on material of human origin such as tissues, specimens and cognitive phenomena) for which an investigator (or colleague) directly interacts with human subjects. This area of research includes: (1) mechanisms of human disease; (2) therapeutic interventions; (3) clinical trials, and; (4) the development of new technologies. Excluded from this definition are in vitro studies that utilize human tissues but do not deal directly with patients. In other words, patient-oriented research is research in which it is necessary to know the identity of the patients from whom the cells or tissues under study are derived. Studies falling under Exemption 4 for human subjects research are not included in this definition. See also the NIH Director's Panel on Clinical Research Report. NIH defines a clinical trial as "A research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes." (NOT-OD-15-015). NIH not only supports trials of safety and efficacy, it also supports mechanistic exploratory studies that meet the definition of a clinical trial and are designed to explore or understand a biological or behavioral process, the pathophysiology of a disease, or the mechanism of action of an intervention. These studies may focus on basic and/or translational discovery research in healthy human subjects and in human subjects who are affected by the pathophysiology of diseases and disorders. By addressing basic questions and concepts in biology, behavior, and pathophysiology, these studies may provide insight into understanding human diseases and disorders along with potential treatments or preventive strategies. NIH also supports biomarker studies that meet the definition of a clinical trial and that may provide information about physiological function, target engagement of novel therapeutics, and/or the impact of therapeutics on treatment response. NIH thus supports studies that meet the definition of clinical trials (as noted above) but do not seek to establish safety, clinical efficacy, effectiveness, clinical management, and/or implementation of preventive, therapeutic, and services interventions. Note: This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to companion FOA Special Note: Because of the differences in individual Institute and Center (IC) program requirements for this FOA, prospective candidates are strongly encouraged to consult the Table of IC-Specific Information, Requirements and Staff Contacts, to make sure that their application is appropriate for the requirements of one of the participating NIH ICs. See Section VIII. Other Information for award authorities and regulations. Section II. Award Information Funding Instrument Grant: A support mechanism providing money, property, or both to an eligible entity to carry out an approved project or activity. Application Types Allowed New Resubmission Revision Renewal The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types. Only those application types listed here are allowed for this FOA. Clinical Trial? Required: Only accepting applications that propose an independent clinical trial(s) Need help determining whether you are doing a clinical trial? Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. Award Budget Award budgets are composed of salary and other program-related expenses, as described below. Award Project Period The total project period may not exceed 5 years.

This funding opportunity supports innovative research projects aimed at advancing the understanding, detection, and treatment of ovarian cancer, targeting early-stage investigators and institutions involved in non-clinical research.

This funding opportunity provides financial support for organizations to implement and evaluate innovative anti-trafficking interventions globally, focusing on prevention, protection, prosecution, and partnerships to combat human trafficking.

This grant provides funding for research on behavioral sleep interventions aimed at improving sleep and mental health outcomes for adolescents and young adults, particularly those from underserved populations.

This funding opportunity supports organizations in Armenia focused on preserving cultural heritage, particularly the intangible cultural traditions of ethnic Armenians displaced from Nagorno-Karabakh.

This funding opportunity is designed for U.S. and Jordanian organizations to implement a youth-focused water conservation project in Jordan, promoting awareness and behavior change around water use through social media engagement.

This grant provides funding for organizations to offer advanced computing resources and support services to researchers in science and engineering, ensuring equitable access and fostering innovation in computational research.

o support research complementary to USGS program efforts in classification of the public lands and examination of the geological structure, water, mineral, and biological resources, and products of the national domain. This entry covers a variety of USGS assistance awards not covered by any other CFDA program entries. Awards are typically supported by funding from internal projects and programs, and funds are not separately budgeted or reserved for external projects or proposals under this entry.

This funding opportunity provides $1.25 million each to organizations that develop and implement innovative strategies to prevent falls among older adults and individuals with disabilities through community-based programs.

The U.S. Department of State, U.S. Embassy Banjul announces an Open Competition for organizations interested in submitting applications for projects that support capacity activities for local civil society organizations (CSOs). Subject to the availability of funding, a grant of up to $500,000 U.S. Dollars in FY 2023 Economic Support Funds (ESF) will be awarded for work that will build the capacity of CSOs which will enable them to effectively engage the government and hold them accountable, help fight corruption and educate the public on key social and human rights issues. Applicants can find application forms and other materials needed to apply on GRANTS.gov https://www.grants.gov/forms/forms-repository/sf-424-mandatory-family and/or U.S. Embassy Banjuls website https://gm.usembassy.gov/grant-opportunities/ under the announcement title Strengthening the Capacity of Civil Society Organizations to Promote Accountable Governance in The Gambia funding opportunity number BJL-ARDF-FY23. Please contact the U.S. Embassy Banjuls point of contact listed in Section G if requesting reasonable accommodations for persons with disabilities or for security reasons. Please note that reasonable accommodations do not include deadline extensions.

This grant provides funding for U.S.-based nonprofit organizations and educational institutions to create reliable editions and translations of important humanities texts, enhancing access and scholarship in American history.

This funding opportunity provides financial support for research sites to study Type 1 diabetic nephropathy by recruiting patients, conducting kidney biopsies, and collecting data to identify new treatment targets and improve precision medicine approaches.

This Cooperative Agreement Notice is a multi-year award thataims to contribute to NASAs mission, Office of STEM Education priorities,Co-STEM goals, Mission Directorate collaborations, and state based needs. The multi-year award will be available to allSpace Grant Consortia who will work with the Office of STEM Engagement tofulfill these objectives. Through thecombined efforts of the Space Grant Consortia, this program will 1) enablecontributions to NASAs work, 2) build a diverse, skilled future workforce, and3) strengthen understanding of STEM through powerful connections to NASA. The program will focus on providingopportunities for students to engage with NASAs aeronautics, space, andscience people, content, and facilities in support of a diverse future NASA andaerospace industry workforce, as well as, providingopportunities for students to contribute to NASAs aeronautics, space, andscience missions and work in exploration and discovery through MissionDirectorate collaborations. Everyinstitution that intends to submit a proposal to this NRA, including theproposed prime award or any partner whether an education institution, and otherorganizations that will serve as sub-awardees or contractors, must be registered in NSPIRES. Electronicsubmission of proposals is required by the due date and must be submitted byan authorized official of the proposing organization. Such registrationmust identify the authorized organizational representative(s) who will submitthe electronic proposal. All principal investigators and other participants(e.g. co-investigators) must be registered in NSPIRES regardless of submissionsystem. Potential proposers and proposing organizations are urged to accessthe system(s) well in advance of the proposal due date(s) of interest tofamiliarize themselves with its structure and enter the requested information.Electronic proposals may be submitted via the NASA proposal data systemNSPIRES. Additional programmatic information for this NRAmay develop before the proposal due date. If so, such information will be addedas a Frequently Asked Question (FAQ) or formal amendment to this NRA and postedon http://nspires.nasaprs.com. It is the proposers responsibility to regularly check NSPIRESfor updates to this NRA. P oint of Contact Name: Erica J. Alston Title: Deputy Space GrantProgram Manager Phone: 757-864-7247 E-mail: [email protected]

Substance use needs to be better incorporated into interventions for the engagement and retention of sexual minority persons in prevention and care with attention to emergent interventions such as long-acting PrEP. Social determinants of health associated with HIV and problematic substance use such as homelessness and criminal justice involvement also demonstrate disproportionate impact among sexual and gender minorities and need attention. Changing self-definition of sexual minority status has implications for outreach and provider stigma and needs to be better integrated into interventions. This initiative will address these gap areas and support epidemiologic, intervention, and implementation research that incorporates attention to HIV as a syndemic including comorbidities such as STIs, HCV, and psychiatric disorder.

This grant provides funding to U.S. institutions to foster collaboration and support early-career researchers in benign urology through training, resource sharing, and professional development opportunities.

This funding opportunity supports a central coordinating center that will enhance collaboration and provide resources for research in nonmalignant hematology, particularly aimed at fostering the development of junior investigators and innovative projects across multiple institutions.